These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8051865)

  • 1. [Candida chorioretinitis: current therapeutic approach].
    Pournaras CJ; Issoua D; Saravelos S; Sunaric G
    Klin Monbl Augenheilkd; 1994 May; 204(5):334-6. PubMed ID: 8051865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida endophthalmitis: focus on current and future antifungal treatment options.
    Khan FA; Slain D; Khakoo RA
    Pharmacotherapy; 2007 Dec; 27(12):1711-21. PubMed ID: 18041891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Endogenous Candida endophthalmitis combined with severe general diseases].
    Stoffelns BM
    Klin Monbl Augenheilkd; 2005 Mar; 222(3):214-7. PubMed ID: 15785983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral endogenous Candida endophthalmitis after induced abortion.
    Sikić J; Vukojević N; Katusić D; Sarić B
    Croat Med J; 2001 Dec; 42(6):676-8. PubMed ID: 11740854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endogenous candida endophthalmitis in a drug dependent patient: intravenous therapy with liposome encapsulated amphotericin B].
    Neppert B; Guthoff R; Heidemann HT
    Klin Monbl Augenheilkd; 1992 Aug; 201(2):122-4. PubMed ID: 1434381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anatomo-clinical and therapeutic aspects of Candida albicans endophthalmitis].
    Brasseur G; Bloch-Michel E; Dhermy P; Charlin JF; Langlois J
    J Fr Ophtalmol; 1982; 5(6-7):393-9. PubMed ID: 6982294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis.
    Essman TF; Flynn HW; Smiddy WE; Brod RD; Murray TG; Davis JL; Rubsamen PE
    Ophthalmic Surg Lasers; 1997 Mar; 28(3):185-94. PubMed ID: 9076791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal liposomal amphotericin B for treatment of endogenous candida endophthalmitis.
    Bae JH; Lee SC
    Jpn J Ophthalmol; 2015 Sep; 59(5):346-52. PubMed ID: 26215152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endogenous aspergillus endophthalmitis: a case repport].
    Maalouf T; Schmitt C; Crance J; George J; Angioi K
    J Fr Ophtalmol; 2000 Feb; 23(2):170-3. PubMed ID: 10705119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-infectious effect of sustained antravitreal amphotericin B drug delivery system on experimental rabbit fungal endophthalmitis of Candida albicans].
    Chen N; Yang YT; Dong XG; Xie LX; Wang SG
    Zhonghua Yan Ke Za Zhi; 2006 May; 42(5):420-5. PubMed ID: 16762236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitrectomy and systemic fluconazole for treatment of endogenous fungal endophthalmitis.
    Christmas NJ; Smiddy WE
    Ophthalmic Surg Lasers; 1996 Dec; 27(12):1012-8. PubMed ID: 8976520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ocular involvement with Candida albicans: report of 2 cases].
    Rebika S; Bonnin N; Borel A; Mrozek N; Vidal M; Rousseau E; Bacin F; Chiambaretta F
    J Fr Ophtalmol; 2015 Apr; 38(4):301-5. PubMed ID: 25842148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endogenous candida endophthalmitis: a new therapy].
    Mistlberger A; Graf B
    Klin Monbl Augenheilkd; 1991 Dec; 199(6):446-9. PubMed ID: 1791689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous Candida endophthalmitis. Management without intravenous amphotericin B.
    Brod RD; Flynn HW; Clarkson JG; Pflugfelder SC; Culbertson WW; Miller D
    Ophthalmology; 1990 May; 97(5):666-72; disc: 672-4. PubMed ID: 2188195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Candida endophthalmitis.
    Kinyoun JL
    Retina; 1982; 2(4):215-22. PubMed ID: 6101128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal lesions as clues to disseminated bacterial and candidal infections: frequency, natural history, and etiology.
    Rodríguez-Adrián LJ; King RT; Tamayo-Derat LG; Miller JW; Garcia CA; Rex JH
    Medicine (Baltimore); 2003 May; 82(3):187-202. PubMed ID: 12792305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long time survival after reduced chemotherapy ina 15-year-old patient with AML and Candida krusei sepsis and eye involvement.
    Bernbeck B; Janssen G; Winterhalter S; Schneider DT; Wessalowski R
    Klin Padiatr; 2009; 221(6):384-5. PubMed ID: 19890793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endogenous mycotic endophthalmitis and pars plana vitrectomy (PPV)].
    Sisková A; Ríhová E; Jandusová J; Dotrelová D; Másová I
    Cesk Slov Oftalmol; 2003 Jan; 59(1):14-22. PubMed ID: 12680117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mycotic endophthalmitis: management and treatment (9 year study)].
    Mora P; Bovey EH; Guex-Crosier Y
    Klin Monbl Augenheilkd; 2002 Apr; 219(4):221-5. PubMed ID: 12022005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal voriconazole for the treatment of endogenous Aspergillus endophthalmitis.
    Kramer M; Kramer MR; Blau H; Bishara J; Axer-Siegel R; Weinberger D
    Ophthalmology; 2006 Jul; 113(7):1184-6. PubMed ID: 16713628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.